Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Cy5 Maleimide for Site-Specific Protein Labeling Workflows
2026-06-13
Cy5 maleimide (non-sulfonated) empowers researchers with precise, high-sensitivity labeling of cysteine residues for advanced protein imaging and tracking. This guide delivers stepwise workflow enhancements, practical troubleshooting, and application insights—leveraging recent literature and APExBIO’s quality reagent for reproducible results.
-
EZ Cap™ Cas9 mRNA (m1Ψ): Precision Genome Editing Unlocked
2026-06-12
EZ Cap™ Cas9 mRNA (m1Ψ) sets a new standard for high-precision genome editing in mammalian cells, thanks to its Cap1 structure, m1Ψ modification, and robust poly(A) tail. This article walks you through optimized workflows, troubleshooting, and the latest advances in controlling Cas9 activity for safer and more effective research.
-
PD0325901: MEK Inhibitor Workflows for Tumor Suppression
2026-06-12
PD0325901 is a potent MEK inhibitor empowering researchers to dissect RAS/RAF/MEK/ERK pathway function, induce cell cycle arrest, and suppress tumor growth with high reproducibility. This article delivers stepwise experimental protocols, troubleshooting insights, and real-world use-cases, translating recent advances in pluripotency and oncology research into actionable laboratory strategies.
-
Genistein in Cancer Research: Cytoskeleton, Autophagy & Chem
2026-06-11
Discover how Genistein, a selective tyrosine kinase inhibitor, advances cancer research by modulating cytoskeleton-dependent autophagy and chemoprevention pathways. This article uniquely bridges mechanotransduction science with practical assay design.
-
Temafloxacin: In Vitro Activity, Pharmacokinetics, and Tissu
2026-06-11
This study systematically evaluates temafloxacin, a fluoroquinolone broad-spectrum antibacterial agent, for its in vitro efficacy against diverse pathogens, its pharmacokinetics, and tissue penetration. The findings highlight temafloxacin’s potent activity across Gram-positive, Gram-negative, and intracellular bacteria, with favorable pharmacokinetic properties, supporting its utility in advanced infectious disease research.
-
KG-501: Strategic Disruption of CREB/CBP in Translational On
2026-06-10
This thought-leadership article explores how KG-501 (3-((4-chlorophenyl)carbamoyl)naphthalen-2-yl dihydrogen phosphate) is redefining transcriptional coactivator disruption in cancer research. We synthesize mechanistic insights, experimental validation, and translational implications—bridging cutting-edge bench findings with actionable guidance for researchers.
-
ROS-Driven Metabolic Rewiring in BRAF Inhibitor-Treated Mela
2026-06-10
Cesi et al. (2017) demonstrate that BRAF inhibitor therapy in melanoma cells elevates reactive oxygen species (ROS), activating pyruvate dehydrogenase kinases (PDKs) and altering central metabolism. This mechanistic insight reveals a metabolic vulnerability in drug-resistant melanoma and supports PDK inhibition as a promising therapeutic strategy.
-
PPP1R3G/PP1γ-Mediated RIPK1 Dephosphorylation Drives Cell De
2026-06-09
This study uncovers how the phosphatase complex PPP1R3G/PP1γ dephosphorylates RIPK1 to promote apoptosis and necroptosis, clarifying a longstanding gap in understanding cell death regulation. These mechanistic insights have direct implications for inflammation and cancer biology research, where precise modulation of NF-κB and RIPK1 pathways is pivotal.
-
5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate
2026-06-09
This article provides a scenario-driven, evidence-based analysis of how 5-hme-dCTP (5-Hydroxymethyl-2’-deoxycytidine-5’-Triphosphate), SKU B8113, addresses laboratory challenges in epigenetic DNA modification research. Bench scientists and postgraduate researchers will benefit from practical Q&A, protocol guidance, and literature-backed recommendations for reliable gene expression and plant drought response studies.
-
Cy5 Maleimide: Advancing Protein Imaging & Condensate Biolog
2026-06-08
This thought-leadership article bridges the gap between mechanistic insight and strategic guidance for translational researchers employing Cy5 maleimide (non-sulfonated) in protein labeling. Drawing upon current advances in protein phase separation and molecular partitioning, it contextualizes the role of thiol-reactive fluorescent dyes in probing electrostatic landscapes within biomolecular condensates—delivering actionable recommendations for translational workflows.
-
Cy5 amine (non-sulfonated): Protocols, QC, and Troubleshooti
2026-06-08
Cy5 amine (non-sulfonated) is a bright, photostable fluorescent probe with a primary amino group, tailored for workflows needing water-insoluble labeling reagents. It is best suited for labeling proteins, peptides, and polymers in fluorescence microscopy and flow cytometry, but should not be used for direct aqueous labeling or clinical diagnostics.
-
Cy5 Maleimide: Precision Fluorescent Labeling in Biomolecule
2026-06-07
Cy5 maleimide (non-sulfonated) empowers protein and peptide labeling workflows with high site-selectivity and robust detection in advanced fluorescence assays. Its unique reactivity and photophysical properties make it the dye of choice for dissecting protein partitioning in cellular condensates and beyond.
-
Sulfo-Cy3 NHS Ester (SKU A8107): Reliable Fluorescent Protei
2026-06-06
This evidence-based guide explores how Sulfo-Cy3 NHS ester (SKU A8107) overcomes common challenges in fluorescent labeling of proteins and peptides for cell viability, proliferation, and cytotoxicity assays. Drawing on peer-reviewed research and best practices, the article demonstrates the product's value as a highly water-soluble, hydrophilic fluorescent dye, supporting reproducible results in demanding biomedical workflows.
-
Mechanistic Leverage: Dual-Reporter mRNA for Translational R
2026-06-05
This article unpacks the strategic and mechanistic advantages of EZ Cap™ Cy5 Firefly Luciferase mRNA (5-moUTP) for translational researchers. By integrating dual-reporter detection, immune evasion, and superior stability features, we explore how this tool transforms mRNA delivery and in vivo imaging workflows—while critically benchmarking its performance against emerging non-viral vectors and industry standards. The discussion bridges recent literature on metal-organic frameworks and protein corona effects, and provides actionable guidance on protocol parameters, experimental design, and future directions for robust, clinically relevant mRNA research.
-
Central Circuits Controlling Opioid-Induced Mechanical Hyper
2026-06-05
Yin et al. (2024) identified a brain-to-spinal neural pathway that governs opioid-induced mechanical hypersensitivity and analgesic tolerance in mice. Their work clarifies the specific neuronal circuitry underlying these phenomena, providing a foundation for targeted interventions in chronic pain and opioid tolerance research.